A detailed history of Enterprise Trust & Investment CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Enterprise Trust & Investment CO holds 8 shares of LLY stock, worth $7,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$7,316
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $2,229 - $2,618
8 New
8 $3,000
Q4 2021

Jan 18, 2022

SELL
$224.85 - $279.04 $112,425 - $139,520
-500 Closed
0 $0
Q3 2021

Oct 14, 2021

SELL
$221.6 - $272.71 $44,320 - $54,541
-200 Reduced 28.57%
500 $116,000
Q2 2021

Jul 12, 2021

BUY
$180.55 - $233.54 $126,385 - $163,478
700 New
700 $161,000
Q2 2020

Jul 15, 2020

SELL
$136.42 - $164.18 $33,286 - $40,059
-244 Closed
0 $0
Q3 2019

Oct 02, 2019

BUY
$106.79 - $116.16 $26,056 - $28,343
244 New
244 $27,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Enterprise Trust & Investment CO Portfolio

Follow Enterprise Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Trust & Investment CO with notifications on news.